CELL AND GENE THERAPY INSIGHTS

July 2026 Issue

Volume 12 Issue 6

Cell and Gene Therapy Insights Volume 12 Issue 6
Download PDF

Featuring

Issue Spotlight: AI & digital transformation in CGT
Vectors focus: Scale-up/out
Other articles
Webinars

SPOTLIGHT

AI & digital transformation in CGT

Foreword

AI in cell and gene therapy – a glimpse into the future while facing reality

AI in cell and gene therapy – a glimpse into the future while facing reality

Nina Bauer
7 August
Read

Review

AI and digital transformation in cell and gene therapy: enabling scalable and predictable biomanufacturing

AI and digital transformation in cell and gene therapy: enabling scalable and predictable biomanufacturing

Preeti Misra
6 August
Read

Viewpoint

AI in CGT needs AI-worthy data, not just better models

AI in CGT needs AI-worthy data, not just better models

Gabriela Lenarczyk
31 July
Read
What CGT can learn from biologics: high‑value AI use cases for manufacturing

What CGT can learn from biologics: high‑value AI use cases for manufacturing

Shyam Panjwani
30 July
Read

Interview

AI-driven LNP design: unlocking non-viral delivery for cell and gene therapy

AI-driven LNP design: unlocking non-viral delivery for cell and gene therapy

Bowen Li
5 August
Read

Vectors FOCUS

Scale-up/out

Innovator Insight

Novel resin design enables efficient enrichment of full AAV capsids by anion exchange chromatography

Novel resin design enables efficient enrichment of full AAV capsids by anion exchange chromatography

Martin Liao
16 July
Read

articles

Innovator Insight

Cryo‑processed leukapheresis using automated closed system: a high‑quality starting material for autologous and allogeneic CAR‑T cell therapy manufacturing

Cryo‑processed leukapheresis using automated closed system: a high‑quality starting material for autologous and allogeneic CAR‑T cell therapy manufacturing

A Michaux, M Rossi, Y Zhang et al.
27 July
Read
Minute-by-minute metabolic control in cell therapy manufacturing: evidence from two real-world case studies

Minute-by-minute metabolic control in cell therapy manufacturing: evidence from two real-world case studies

Nick Randall, Arvind Padma
23 July
Read
Standardizing CAR‑T quality control: dPCR‑based approaches for reliable VCN and RCL testing

Standardizing CAR‑T quality control: dPCR‑based approaches for reliable VCN and RCL testing

Arvind Padma
14 July
Read
From IND to BLA: building defensible analytical strategies for cell therapy

From IND to BLA: building defensible analytical strategies for cell therapy

M Brewer, C Chen, D Marshall et al.
2 July
Read
Controlled ATMP freezing: the role of cooling rate and phase transition control in cell viability

Controlled ATMP freezing: the role of cooling rate and phase transition control in cell viability

Alexander Fuchs, Carola Feigl
29 June
Read

Infographic

The industry speaks: what is the future of CAR-T cell therapy?

The industry speaks: what is the future of CAR-T cell therapy?

20 July
Read

Industry Insights

Industry Insights: Expanding access across the field, from pediatric approvals to the first solid tumor CAR‑T

Industry Insights: Expanding access across the field, from pediatric approvals to the first solid tumor CAR‑T

Abigail Pinchbeck
4 August
Read

Webinars